Critical issues in delivery of RNAi therapeutics in vivo

Current Pharmaceutical Biotechnology

Volumn 13, Issue 7, 2012, Pages 1279-1291

  Rivera, Stephanie ^a   Yuan, Fan ^a  

^a Duke University   (United States)

Author keywords

Physiological barriers; RNA delivery; RNA interference; Transport

Indexed keywords

ADENOVIRUS VECTOR; CELL PENETRATING PEPTIDE; HERPESVIRUS VECTOR; LENTIVIRUS VECTOR; NANOPARTICLE; PARVOVIRUS VECTOR; RETROVIRUS VECTOR; RNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

BALLISTICS; BIOLISTIC TRANSFORMATION; CYTOTOXICITY; GENE DELIVERY SYSTEM; HUMAN; HYDRODYNAMICS; IMMUNOGENICITY; IN VIVO STUDY; MOLECULARLY TARGETED THERAPY; NONHUMAN; OSMOSIS; REVIEW; RNA INTERFERENCE; RNA STABILITY; RNA TRANSPORT; SONOPORATION; VIRAL GENE DELIVERY SYSTEM;

EID: 84858978420     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112800624300     Document Type: Review

References (142)

1. Fire, A.; Xu, S.; Montgomery, M. K.; Kostas, S. A.; Driver, S. E.; Mello, C. C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 1998, 391, 806-811.
2. Das, R. M.; Van Hateren, N. J.; Howell, G. R.; Farrell, E. R.; Bangs, F. K.; Porteous, V. C.; Manning, E. M.; McGrew, M. J.; Ohyama, K.; Sacco, M. A.; Halley, P. A.; Sang, H. M.; Storey, K. G.; Placzek, M.; Tickle, C.; Nair, V. K.; Wilson, S. A. A robust system for RNA interference in the chicken using a modified microRNA operon. Dev. Biol., 2006, 294, 554-563.
3. Rana, T. M. Illuminating the silence: understanding the structure and function of small RNAs. Nat. Rev. Mol. Cell Biol., 2007, 8, 23-36.
4. Han, J.; Kim, D.; Morris, K. V. Promoter-associated RNA is required for RNA-directed transcriptional gene silencing in human cells. Proc. Natl. Acad. Sci. USA, 2007, 104, 12422-12427.
5. Kim, J.; Inoue, K.; Ishii, J.; Vanti, W. B.; Voronov, S. V.; Murchison, E.; Hannon, G.; Abeliovich, A. A MicroRNA feedback circuit in midbrain dopamine neurons. Science, 2007, 317, 1220-1224.
6. Eulalio, A.; Huntzinger, E.; Izaurralde, E. Getting to the root of miRNA-mediated gene silencing. Cell, 2008, 132, 9-14.
7. Winter, J.; Jung, S.; Keller, S.; Gregory, R. I.; Diederichs, S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol., 2009, 11, 228-34.
8. Kim, D. H.; Rossi, J. J. Strategies for silencing human disease using RNA interference. Nat. Rev. Genet, 2007, 8, 173-184.
9. de Fougerolles, A.; Vornlocher, H. P.; Maraganore, J.; Lieberman, J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat. Rev. Drug Discov., 2007, 6, 443-453.
10. Huppi, K.; Martin, S. E.; Caplen, N. J. Defining and assaying RNAi in mammalian cells. Mol. Cell, 2005, 17, 1-10.
11. Vasudevan, S.; Tong, Y.; Steitz, J. A. Switching from repression to activation: microRNAs can up-regulate translation. Science, 2007, 318, 1931-1934.
12. Bentwich, I.; Avniel, A.; Karov, Y.; Aharonov, R.; Gilad, S.; Barad, O.; Barzilai, A.; Einat, P.; Einav, U.; Meiri, E.; Sharon, E.; Spector, Y.; Bentwich, Z. Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet., 2005, 37, 766-770.
13. Wu, W.; Sun, M.; Zou, G. M.; Chen, J. MicroRNA and cancer: Current status and prospective. Int. J. Cancer, 2007, 120, 953-60.
14. Lewis, B. P.; Burge, C. B.; Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 2005, 120, 15-20.
15. Grimm, D. Small silencing RNAs: state-of-the-art. Adv. Drug Deliv. Rev., 2009, 61, 672-703.
16. Grimm, D.; Kay, M. A. Therapeutic application of RNAi: is mRNA targeting finally ready for prime time? J. Clin. Invest., 2007, 117, 3633-3641.
17. Whitehead, K. A.; Langer, R.; Anderson, D. G. Knocking down barriers: advances in siRNA delivery. Nat. Rev. Drug Discov., 2009, 8, 129-138.
18. Hoelters, J.; Ciccarella, M.; Drechsel, M.; Geissler, C.; Gulkan, H.; Bocker, W.; Schieker, M.; Jochum, M.; Neth, P. Nonviral genetic modification mediates effective transgene expression and functional RNA interference in human mesenchymal stem cells. J. Gene Med., 2005, 7, 718-728.
19. Bumcrot, D.; Manoharan, M.; Koteliansky, V.; Sah, D. W. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat. Chem. Biol., 2006, 2, 711-719.
20. Siolas, D.; Lerner, C.; Burchard, J.; Ge, W.; Linsley, P. S.; Paddison, P. J.; Hannon, G. J.; Cleary, M. A. Synthetic shRNAs as potent RNAi triggers. Nat. Biotechnol., 2005, 23, 227-231.
21. Eulalio, A.; Behm-Ansmant, I.; Izaurralde, E. P bodies: at the crossroads of post-transcriptional pathways. Nat. Rev. Mol. Cell Biol., 2007, 8, 9-22.
22. Kozlov, G.; Safaee, N.; Rosenauer, A.; Gehring, K. Structural basis of binding of P-body-associated proteins GW182 and ataxin-2 by the Mlle domain of poly(A)-binding protein. J. Biol. Chem., 2010, 285, 13599-13606.
23. Moser, J. J.; Fritzler, M. J. Cytoplasmic ribonucleoprotein (RNP) bodies and their relationship to GW/P bodies. Int. J. Biochem. Cell Biol., 2010, 42, 828-843.
24. Meister, G.; Tuschl, T. Mechanisms of gene silencing by doublestranded RNA. Nature, 2004, 431, 343-349.
25. Boden, D.; Pusch, O.; Silbermann, R.; Lee, F.; Tucker, L.; Ramratnam, B. Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins. Nucleic Acids Res., 2004, 32, 1154-1158.
26. Elbashir, S. M.; Harborth, J.; Lendeckel, W.; Yalcin, A.; Weber, K.; Tuschl, T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 2001, 411, 494-498.
27. Martin, S. E.; Caplen, N. J. Applications of RNA interference in mammalian systems. Annu. Rev. Genom. Hum. Genet., 2007, 8, 81-108.
28. Howard, B. A.; Furumai, R.; Campa, M. J.; Rabbani, Z. N.; Vujaskovic, Z.; Wang, X. F.; Patz, E. F., Jr. Stable RNA interferencemediated suppression of cyclophilin A diminishes non-small-cell lung tumor growth in vivo. Cancer Res., 2005, 65, 8853-8860.
29. Chen, W.; Liu, M.; Jiao, Y.; Yan, W.; Wei, X.; Chen, J.; Fei, L.; Liu, Y.; Zuo, X.; Yang, F.; Lu, Y.; Zheng, Z. Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo. J. Virol., 2006, 80, 3559-3566.
30. Sanchez, A. B.; Perez, M.; Cornu, T.; de la Torre, J. C. RNA interference-mediated virus clearance from cells both acutely and chronically infected with the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol., 2005, 79, 11071-11081.
31. Davis, M. E.; Zuckerman, J. E.; Choi, C. H.; Seligson, D.; Tolcher, A.; Alabi, C. A.; Yen, Y.; Heidel, J. D.; Ribas, A. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature, 2010, 464, 1067-1070.
32. Carette, J. E.; Overmeer, R. M.; Schagen, F. H.; Alemany, R.; Barski, O. A.; Gerritsen, W. R.; Van Beusechem, V. W. Conditionally replicating adenoviruses expressing short hairpin RNAs silence the expression of a target gene in cancer cells. Cancer Res., 2004, 64, 2663-2667.
33. Calin, G. A.; Sevignani, C.; Dumitru, C. D.; Hyslop, T.; Noch, E.; Yendamuri, S.; Shimizu, M.; Rattan, S.; Bullrich, F.; Negrini, M.; Croce, C. M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA, 2004, 101, 2999-3004.
34. Esquela-Kerscher, A.; Slack, F. J. Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer, 2006, 6, 259-269.
35. Zhang, B.; Pan, X.; Cobb, G. P.; Anderson, T. A. microRNAs as oncogenes and tumor suppressors. Dev. Biol., 2007, 302, 1-12.
36. Calin, G. A.; Croce, C. M. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res., 2006, 66, 7390-7394.
37. Gregory, R. I.; Shiekhattar, R. MicroRNA biogenesis and cancer. Cancer Res., 2005, 65, 3509-3512.
38. Johnson, S. M.; Grosshans, H.; Shingara, J.; Byrom, M.; Jarvis, R.; Cheng, A.; Labourier, E.; Reinert, K. L.; Brown, D.; Slack, F. J. RAS is regulated by the let-7 microRNA family. Cell, 2005, 120, 635-647.
39. Stram, Y.; Kuzntzova, L. Inhibition of viruses by RNA interference. Virus Genes., 2006, 32, 299-306.
40. Davis, M. E. The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol. Pharm., 2009, 6, 659-668.
41. Jain, R. K. Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. J. Control Release, 2001, 74, 7-25.
42. Wang, Y.; Yuan, F. Delivery of viral vectors to tumor cells: extracellular transport, systemic distribution, and strategies for improvement. Ann. Biomed. Eng., 2006, 34, 114-127.
43. Henshaw, J. W.; Yuan, F. Field distribution and DNA transport in solid tumors during electric field-mediated gene delivery. J. Pharm. Sci., 2008, 97, 691-711.
44. Dominska, M.; Dykxhoorn, D. M. Breaking down the barriers: siRNA delivery and endosome escape. J. Cell Sci., 2010, 123, 1183-1189.
45. Luo, M. C.; Zhang, D. Q.; Ma, S. W.; Huang, Y. Y.; Shuster, S. J.; Porreca, F.; Lai, J. An efficient intrathecal delivery of small interfering RNA to the spinal cord and peripheral neurons. Mol. Pain., 2005, 1, 29.
46. Yuan, F. Transvascular drug delivery in solid tumors. Semin. Radiat. Oncol., 1998, 8, 164-175.
47. Yuan, F.; Leunig, M.; Huang, S. K.; Berk, D. A.; Papahadjopoulos, D.; Jain, R. K. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res., 1994, 54, 3352-3356.
48. Krol, A.; Dewhirst, M. W.; Yuan, F. Effects of cell damage and glycosaminoglycan degradation on available extravascular space of different dextrans in a rat fibrosarcoma. Int. J Hyperthermia, 2003, 19, 154-164.
49. Krol, A.; Maresca, J.; Dewhirst, M. W.; Yuan, F. Available volume fraction of macromolecules in the extravascular space of a fibrosarcoma: implications for drug delivery. Cancer Res., 1999, 59, 4136-4141.
50. McGuire, S.; Yuan, F. Quantitative analysis of intratumoral infusion of color molecules. Am. J. Physiol. Heart Circ. Physiol., 2001, 281, H715-721.
51. McGuire, S.; Zaharoff, D.; Yuan, F. In: Pharmaceutical Perspectives of Nucleic Acid-Based Therapeutics, R. I. Mahato; S. W. Kim, eds.; Taylor & Francis Books: London, 2002, pp. 434-454.
52. McGuire, S.; Zaharoff, D.; Yuan, F. Nonlinear dependence of hydraulic conductivity on tissue deformation during intratumoral infusion. Ann. Biomed. Eng., 2006, 34, 1173-1181.
53. Yuan, F.; Krol, A.; Tong, S. Available space and extracellular transport of macromolecules: effects of pore size and connectedness. Ann. Biomed. Eng., 2001, 29, 1150-1158.
54. Jain, R. K. Delivery of molecular and cellular medicine to solid tumors. Adv. Drug Deliv. Rev., 1997, 26, 71-90.
55. Juweid, M.; Neumann, R.; Paik, C.; Perez-Bacete, M. J.; Sato, J.; van Osdol, W.; Weinstein, J. N. Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. Cancer Res., 1992, 52, 5144-5153.
56. Juliano, R.; Bauman, J.; Kang, H.; Ming, X. Biological barriers to therapy with antisense and siRNA oligonucleotides. Mol. Pharm., 2009, 6, 686-695.
57. Dincer, S.; Turk, M.; Piskin, E. Intelligent polymers as nonviral vectors. Gene. Ther., 2005, 12 (Suppl 1), S139-145.
58. Nishikawa, M.; Huang, L. Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum. Gene. Ther., 2001, 12, 861-870.
59. Subramanian, A.; Ranganathan, P.; Diamond, S. L. Nuclear targeting peptide scaffolds for lipofection of nondividing mammalian cells. Nat. Biotechnol., 1999, 17, 873-877.
60. Wattiaux, R.; Laurent, N.; Wattiaux-De Coninck, S.; Jadot, M. Endosomes, lysosomes: their implication in gene transfer. Adv. Drug Deliv. Rev., 2000, 41, 201-208.
61. Lukacs, G. L.; Haggie, P.; Seksek, O.; Lechardeur, D.; Freedman, N.; Verkman, A. S. Size-dependent DNA mobility in cytoplasm and nucleus. J. Biol. Chem., 2000, 275, 1625-1629.
62. Gorlich, D.; Mattaj, I. W. Nucleocytoplasmic transport. Science, 1996, 271, 1513-1518.
63. Ledley, F. D. Pharmaceutical approach to somatic gene therapy. Pharm. Res., 1996, 13, 1595-614.
64. Dingwall, C.; Laskey, R. A. Nuclear targeting sequences--a consensus? Trends Biochem. Sci., 1991, 16, 478-481.
65. Braasch, D. A.; Jensen, S.; Liu, Y.; Kaur, K.; Arar, K.; White, M. A.; Corey, D. R. RNA interference in mammalian cells by chemically-modified RNA. Biochemistry, 2003, 42, 7967-7975.
66. Soutschek, J.; Akinc, A.; Bramlage, B.; Charisse, K.; Constien, R.; Donoghue, M.; Elbashir, S.; Geick, A.; Hadwiger, P.; Harborth, J.; John, M.; Kesavan, V.; Lavine, G.; Pandey, R. K.; Racie, T.; Rajeev, K. G.; Rohl, I.; Toudjarska, I.; Wang, G.; Wuschko, S.; Bumcrot, D.; Koteliansky, V.; Limmer, S.; Manoharan, M.; Vornlocher, H. P. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature, 2004, 432, 173-178.
67. Ikeda, Y.; Taira, K. Ligand-targeted delivery of therapeutic siRNA. Pharm. Res., 2006, 23, 1631-1640.
68. Wolfrum, C.; Shi, S.; Jayaprakash, K. N.; Jayaraman, M.; Wang, G.; Pandey, R. K.; Rajeev, K. G.; Nakayama, T.; Charrise, K.; Ndungo, E. M.; Zimmermann, T.; Koteliansky, V.; Manoharan, M.; Stoffel, M. Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nat. Biotechnol., 2007, 25, 1149-1157.
69. Agrawal, S. Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides. Biochim. Biophys. Acta, 1999, 1489, 53-68.
70. Pasut, G.; Guiotto, A.; Veronese, F. Protein, peptide and nonpeptide drug PEGylation for therapeutic application. Exp. Opin. Ther. Patents, 2004, 14, 859-894.
71. Putnam, D. Polymers for gene delivery across length scales. Nat. Mater., 2006, 5, 439-451.
72. Duncan, R.; Izzo, L. Dendrimer biocompatibility and toxicity. Adv. Drug Deliv. Rev., 2005, 57, 2215-2237.
73. Merdan, T.; Kopecek, J.; Kissel, T. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv. Drug Deliv. Rev., 2002, 54, 715-758.
74. Park, T. G.; Jeong, J. H.; Kim, S. W. Current status of polymeric gene delivery systems. Adv. Drug Deliv. Rev., 2006, 58, 467-486.
75. Fedorov, Y.; Anderson, E. M.; Birmingham, A.; Reynolds, A.; Karpilow, J.; Robinson, K.; Leake, D.; Marshall, W. S.; Khvorova, A. Off-target effects by siRNA can induce toxic phenotype. RNA, 2006, 12, 1188-1196.
76. Oleinikov, A. V.; Zhao, J.; Gray, M. D. RNA interference by mixtures of siRNAs prepared using custom oligonucleotide arrays. Nucleic Acids Res., 2005, 33, e92.
77. Grimm, D.; Streetz, K. L.; Jopling, C. L.; Storm, T. A.; Pandey, K.; Davis, C. R.; Marion, P.; Salazar, F.; Kay, M. A. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature, 2006, 441, 537-541.
78. Marsden, P. A. RNA interference as potential therapy--not so fast. N. Engl. J. Med., 2006, 355, 953-954.
79. Ehlert, E. M.; Eggers, R.; Niclou, S. P.; Verhaagen, J. Cellular toxicity following application of adeno-associated viral vector-mediated RNA interference in the nervous system. BMC Neurosci., 2010, 11, 20.
80. Vasileva, A.; Linden, R. M.; Jessberger, R. Homologous recombination is required for AAV-mediated gene targeting. Nucleic Acids Res., 2006, 34, 3345-3360.
81. Golding, M. C.; Long, C. R.; Carmell, M. A.; Hannon, G. J.; Westhusin, M. E. Suppression of prion protein in livestock by RNA interference. Proc. Natl. Acad. Sci. USA, 2006, 103, 5285-5290.
82. Galanis, E.; Vile, R.; Russell, S. J. Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors. Crit. Rev. Oncol. Hematol., 2001, 38, 177-192.
83. Stone, D.; David, A.; Bolognani, F.; Lowenstein, P. R.; Castro, M. G. Viral vectors for gene delivery and gene therapy within the endocrine system. J. Endocrinol., 2000, 164, 103-118.
84. Young, L. S.; Searle, P. F.; Onion, D.; Mautner, V. Viral gene therapy strategies: from basic science to clinical application. J. Pathol., 2006, 208, 299-318.
85. Dean, D. A. Nonviral gene transfer to skeletal, smooth, and cardiac muscle in living animals. Am. J. Physiol. Cell Physiol., 2005, 289, C233-245.
86. Gao, K.; Huang, L. Nonviral methods for siRNA delivery. Mol. Pharm., 2009, 6, 651-658.
87. Hobel, S.; Koburger, I.; John, M.; Czubayko, F.; Hadwiger, P.; Vornlocher, H. P.; Aigner, A. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab. J. Gene. Med., 2010, 12, 287-300.
88. Aoki, M.; Ishii, T.; Kanaoka, M.; Kimura, T. RNA interference in immune cells by use of osmotic delivery of siRNA. Biochem. Biophys. Res. Commun., 2006, 341, 326-333.
89. Akaneya, Y.; Jiang, B.; Tsumoto, T. RNAi-induced gene silencing by local electroporation in targeting brain region. J. Neurophysiol., 2005, 93, 594-602.
90. Shefi, O.; Simonnet, C.; Baker, M. W.; Glass, J. R.; Macagno, E. R.; Groisman, A. Microtargeted gene silencing and ectopic expression in live embryos using biolistic delivery with a pneumatic capillary gun. J. Neurosci., 2006, 26, 6119-6123.
91. Chen, Z.; Liang, K.; Xie, M.; Wang, X.; Lu, Q.; Zhang, J. Novel ultrasound-targeted microbubble destruction mediated short hairpin RNA plasmid transfection targeting survivin inhibits gene expression and induces apoptosis of HeLa cells. Mol. Biol. Rep., 2009, 36, 2059-2067.
92. Kinoshita, M.; Hynynen, K. A novel method for the intracellular delivery of siRNA using microbubble-enhanced focused ultrasound. Biochem. Biophys. Res. Commun., 2005, 335, 393-399.
93. Musatov, S.; Chen, W.; Pfaff, D. W.; Kaplitt, M. G.; Ogawa, S. RNAi-mediated silencing of estrogen receptor {alpha} in the ventromedial nucleus of hypothalamus abolishes female sexual behaviors. Proc. Natl. Acad. Sci. USA, 2006, 103, 10456-10460.
94. Chen, M.; Payne, W. S.; Dunn, J. R.; Chang, S.; Zhang, H. M.; Hunt, H. D.; Dodgson, J. B. Retroviral delivery of RNA interference against Marek's disease virus in vivo. Poult Sci., 2009, 88, 1373-1380.
95. Suzuki, T.; Nishida, K.; Kakutani, K.; Maeno, K.; Yurube, T.; Takada, T.; Kurosaka, M.; Doita, M. Sustained long-term RNA interference in nucleus pulposus cells in vivo mediated by unmodified small interfering RNA. Eur. Spine J., 2009, 18, 263-270.
96. Veldhoen, S.; Laufer, S. D.; Trampe, A.; Restle, T. Cellular delivery of small interfering RNA by a non-covalently attached cellpenetrating peptide: quantitative analysis of uptake and biological effect. Nucleic Acids Res., 2006, 34, 6561-6573.
97. Eguchi, A.; Meade, B. R.; Chang, Y. C.; Fredrickson, C. T.; Willert, K.; Puri, N.; Dowdy, S. F. Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein. Nat. Biotechnol., 2009, 27, 567-571.
98. Li, S. D.; Huang, L. Surface-modified LPD nanoparticles for tumor targeting. Ann. N. Y. Acad. Sci., 2006, 1082, 1-8.
99. Oishi, M.; Nakaogami, J.; Ishii, T.; Nagasaki, Y. Smart PEGylated gold nanoparticles for the cytoplasmic delivery of siRNA to induce enhanced gene silencing. Chem. Lett., 2006, 35, 1046-1047.
100. Tönges, L.; Lingor, P.; Egle, R.; Dietz, G. P.; Fahr, A.; Bahr, M. Stearylated octaarginine and artificial virus-like particles for transfection of siRNA into primary rat neurons. RNA, 2006, 12, 1431-1438.
101. Jazag, A.; Kanai, F.; Ijichi, H.; Tateishi, K.; Ikenoue, T.; Tanaka, Y.; Ohta, M.; Imamura, J.; Guleng, B.; Asaoka, Y.; Kawabe, T.; Miyagishi, M.; Taira, K.; Omata, M. Single small-interfering RNA expression vector for silencing multiple transforming growth factor-beta pathway components. Nucleic Acids Res., 2005, 33, e131.
102. Campbell, M.; Kiang, A. S.; Kenna, P. F.; Kerskens, C.; Blau, C.; O'Dwyer, L.; Tivnan, A.; Kelly, J. A.; Brankin, B.; Farrar, G. J.; Humphries, P. RNAi-mediated reversible opening of the bloodbrain barrier. J. Gene. Med., 2008, 10, 930-947.
103. Nakai, N.; Kishida, T.; Shin-Ya, M.; Imanishi, J.; Ueda, Y.; Kishimoto, S.; Mazda, O. Therapeutic RNA interference of malignant melanoma by electrotransfer of small interfering RNA targeting Mitf. Gene. Ther., 2007, 14, 357-365.
104. Niola, F.; Evangelisti, C.; Campagnolo, L.; Massalini, S.; Bue, M. C.; Mangiola, A.; Masotti, A.; Maira, G.; Farace, M. G.; Ciafre, S. A. A plasmid-encoded VEGF siRNA reduces glioblastoma angiogenesis and its combination with interleukin-4 blocks tumor growth in a xenograft mouse model. Cancer Biol. Ther., 2006, 5, 174-179.
105. Takei, Y.; Kadomatsu, K.; Yuzawa, Y.; Matsuo, S.; Muramatsu, T. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res., 2004, 64, 3365-3370.
106. Morris, K. V.; Rossi, J. J. Lentivirus-mediated RNA interference therapy for human immunodeficiency virus type 1 infection. Hum. Gene Ther., 2006, 17, 479-486.
107. Liao, W.; Ning, G. Knockdown of apolipoprotein B, an atherogenic apolipoprotein, in HepG2 cells by lentivirus-mediated siRNA. Biochem. Biophys. Res. Commun., 2006, 344, 478-483.
108. Barquinero, J.; Eixarch, H.; Perez-Melgosa, M. Retroviral vectors: new applications for an old tool. Gene Ther., 2004, 11 (Suppl 1), S3-9.
109. Lee, J. M.; Takahashi, M.; Mon, H.; Koga, K.; Kawaguchi, Y.; Kusakabe, T. Efficient gene transfer into silkworm larval tissues by a combination of sonoporation and lipofection. Cell Biol. Int., 2005, 29, 976-979.
110. Bain, J. R.; Schisler, J. C.; Takeuchi, K.; Newgard, C. B.; Becker, T. C. An adenovirus vector for efficient RNA interferencemediated suppression of target genes in insulinoma cells and pancreatic islets of langerhans. Diabetes, 2004, 53, 2190-2194.
111. Hao, D. L.; Liu, C. M.; Dong, W. J.; Gong, H.; Wu, X. S.; Liu, D. P.; Liang, C. C. Knockdown of human p53 gene expression in 293-T cells by retroviral vector-mediated short hairpin RNA. Acta. Biochim. Biophys. Sin (Shanghai), 2005, 37, 779-783.
112. Duxbury, M. S.; Ito, H.; Benoit, E.; Zinner, M. J.; Ashley, S. W.; Whang, E. E. Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic cancer. Surgery, 2004, 136, 261-269.
113. Amar, L.; Desclaux, M.; Faucon-Biguet, N.; Mallet, J.; Vogel, R. Control of small inhibitory RNA levels and RNA interference by doxycycline induced activation of a minimal RNA polymerase III promoter. Nucleic Acids Res., 2006, 34, e37.
114. Bessis, N.; GarciaCozar, F. J.; Boissier, M. C. Immune responses to gene therapy vectors: influence on vector function and effector mechanisms. Gene. Ther., 2004, 11 (Suppl 1), S10-17.
115. Machida, Y.; Okada, T.; Kurosawa, M.; Oyama, F.; Ozawa, K.; Nukina, N. rAAV-mediated shRNA ameliorated neuropathology in Huntington disease model mouse. Biochem. Biophys. Res. Commun., 2006, 343, 190-197.
116. Suckau, L.; Fechner, H.; Chemaly, E.; Krohn, S.; Hadri, L.; Kockskamper, J.; Westermann, D.; Bisping, E.; Ly, H.; Wang, X.; Kawase, Y.; Chen, J.; Liang, L.; Sipo, I.; Vetter, R.; Weger, S.; Kurreck, J.; Erdmann, V.; Tschope, C.; Pieske, B.; Lebeche, D.; Schultheiss, H. P.; Hajjar, R. J.; Poller, W. C. Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy. Circulation, 2009, 119, 1241-1252.
117. Lambeth, L. S.; Zhao, Y.; Smith, L. P.; Kgosana, L.; Nair, V. Targeting Marek's disease virus by RNA interference delivered from a herpesvirus vaccine. Vaccine, 2009, 27, 298-306.
118. Gresch, O.; Engel, F. B.; Nesic, D.; Tran, T. T.; England, H. M.; Hickman, E. S.; Korner, I.; Gan, L.; Chen, S.; Castro-Obregon, S.; Hammermann, R.; Wolf, J.; Muller-Hartmann, H.; Nix, M.; Siebenkotten, G.; Kraus, G.; Lun, K. New non-viral method for gene transfer into primary cells. Methods, 2004, 33, 151-163.
119. Bitko, V.; Musiyenko, A.; Shulyayeva, O.; Barik, S. Inhibition of respiratory viruses by nasally administered siRNA. Nat. Med., 2005, 11, 50-55.
120. Howard, K. A.; Rahbek, U. L.; Liu, X.; Damgaard, C. K.; Glud, S. Z.; Andersen, M. O.; Hovgaard, M. B.; Schmitz, A.; Nyengaard, J. R.; Besenbacher, F.; Kjems, J. RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. Mol. Ther., 2006, 14, 476-484.
121. Aigner, A. Delivery systems for the direct application of siRNAs to induce RNA interference (RNAi) in vivo. J. Biomed. Biotechnol., 2006, 2006, 71659.
122. Urban-Klein, B.; Werth, S.; Abuharbeid, S.; Czubayko, F.; Aigner, A. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene. Ther., 2005, 12, 461-466.
123. Sato, A. K.; Viswanathan, M.; Kent, R. B.; Wood, C. R. Therapeutic peptides: technological advances driving peptides into development. Curr. Opin. Biotechnol., 2006, 17, 638-642.
124. Chiu, Y. L.; Ali, A.; Chu, C. Y.; Cao, H.; Rana, T. M. Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells. Chem. Biol., 2004, 11, 1165-1175.
125. Kumar, P.; Wu, H.; McBride, J. L.; Jung, K. E.; Kim, M. H.; Davidson, B. L.; Lee, S. K.; Shankar, P.; Manjunath, N. Transvascular delivery of small interfering RNA to the central nervous system. Nature, 2007, 448, 39-43.
126. Song, E.; Zhu, P.; Lee, S. K.; Chowdhury, D.; Kussman, S.; Dykxhoorn, D. M.; Feng, Y.; Palliser, D.; Weiner, D. B.; Shankar, P.; Marasco, W. A.; Lieberman, J. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat. Biotechnol., 2005, 23, 709-717.
127. McNamara, J. O., 2nd; Andrechek, E. R.; Wang, Y.; Viles, K. D.; Rempel, R. E.; Gilboa, E.; Sullenger, B. A.; Giangrande, P. H. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat. Biotechnol., 2006, 24, 1005-1015.
128. Kumar, P.; Ban, H. S.; Kim, S. S.; Wu, H.; Pearson, T.; Greiner, D. L.; Laouar, A.; Yao, J.; Haridas, V.; Habiro, K.; Yang, Y. G.; Jeong, J. H.; Lee, K. Y.; Kim, Y. H.; Kim, S. W.; Peipp, M.; Fey, G. H.; Manjunath, N.; Shultz, L. D.; Lee, S. K.; Shankar, P. T cellspecific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell, 2008, 134, 577-586.
129. Mitragotri, S. Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat. Rev. Drug Discov., 2005, 4, 255-260.
130. Lu, X.; Sankin, G.; Pua, E. C.; Madden, J.; Zhong, P. Activation of transgene expression in skeletal muscle by focused ultrasound. Biochem. Biophys. Res. Commun., 2009, 379, 428-433.
131. Zarnitsyn, V. G.; Prausnitz, M. R. Physical parameters influencing optimization of ultrasound-mediated DNA transfection. Ultrasound Med. Biol., 2004, 30, 527-538.
132. Tsunoda, S.; Mazda, O.; Oda, Y.; Iida, Y.; Akabame, S.; Kishida, T.; Shin-Ya, M.; Asada, H.; Gojo, S.; Imanishi, J.; Matsubara, H.; Yoshikawa, T. Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart. Biochem. Biophys. Res. Commun., 2005, 336, 118-127.
133. Okada, C. Y.; Rechsteiner, M. Introduction of macromolecules into cultured mammalian cells by osmotic lysis of pinocytic vesicles. Cell, 1982, 29, 33-41.
134. Gruber, J.; Boese, G.; Tuschl, T.; Osborn, M.; Weber, K. RNA interference by osmotic lysis of pinosomes: liposome-independent transfection of siRNAs into mammalian cells. Biotechniques, 2004, 37, 96-102.
135. Tanaka, M.; Yanagawa, Y.; Hirashima, N. Transfer of small interfering RNA by single-cell electroporation in cerebellar cell cultures. J. Neurosci. Methods, 2009, 178, 80-86.
136. Mossop, B. J.; Barr, R. C.; Henshaw, J. W.; Zaharoff, D. A.; Yuan, F. Electric fields in tumors exposed to external voltage sources: implication for electric field-mediated drug and gene delivery. Ann. Biomed. Eng., 2006, 34, 1564-1572.
137. Takahashi, Y.; Nishikawa, M.; Takakura, Y. Suppression of tumor growth by intratumoral injection of short hairpin RNA-expressing plasmid DNA targeting beta-catenin or hypoxia-inducible factor 1alpha. J. Control Release, 2006, 116, 90-95.
138. Takayama, K.; Suzuki, A.; Manaka, T.; Taguchi, S.; Hashimoto, Y.; Imai, Y.; Wakitani, S.; Takaoka, K. RNA interference for nog gin enhances the biological activity of bone morphogenetic proteins in vivo and in vitro. J. Bone Miner. Metab., 2009, 27, 402-411.
139. Gonzalez-Gonzalez, E.; Lopez-Casas, P. P.; Del Mazo, J. Gene silencing by RNAi in mouse Sertoli cells. Reprod. Biol. Endocrinol., 2008, 6, 29.
140. Kobayashi, N.; Matsui, Y.; Kawase, A.; Hirata, K.; Miyagishi, M.; Taira, K.; Nishikawa, M.; Takakura, Y. Vector-based in vivo RNA interference: dose-and time-dependent suppression of transgene expression. J. Pharmacol. Exp. Ther., 2004, 308, 688-693.
141. McAnuff, M. A.; Rettig, G. R.; Rice, K. G. Potency of siRNA versus shRNA mediated knockdown in vivo. J. Pharm. Sci., 2007, 96, 2922-30.
142. Liu, F.; Song, Y.; Liu, D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene. Ther., 1999, 6, 1258-1266.